Champions Oncology, Inc. (CSBR)
NASDAQ · Healthcare
Champions Oncology, Inc. Revenue 2018–2025
Champions Oncology, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Champions Oncology, Inc. revenue for the quarter ending January 31, 2026 was 16.6 M, a 2.82% decrease year-over-year.
- Champions Oncology, Inc. revenue for the twelve months ending January 31, 2026 was 62.6 M, a 22.46% increase year-over-year.
- Champions Oncology, Inc. annual revenue for 2025 was 56.9 M, a 13.54% increase from 2024.
- Champions Oncology, Inc. annual revenue for 2024 was 50.2 M, a 6.90% decrease from 2023.
- Champions Oncology, Inc. annual revenue for 2023 was 53.9 M, a 9.69% increase from 2022.
- Champions Oncology, Inc. annual revenue for 2022 was 49.1 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Champions Oncology, Inc. Revenue — FAQ
Champions Oncology, Inc. (CSBR) revenue over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Champions Oncology, Inc.'s revenue?
Champions Oncology, Inc. (CSBR) reported revenue of $57M for fiscal 2025.
Where can I see CSBR's revenue history?
The chart and table above show Champions Oncology, Inc.'s revenue by year and by quarter, including the growth rate.